Sampling Plans, Treatability Plans, [_____]) management and other
distributive costs, mobilization, sampling and analysis, site work,
excavation, [_____].
3.1.7.3
Costs Directly Associated with Treatment
The costs directly associated with the treatment shall include solids,
liquid, vapor preparation and handling; mobilization, spill control,
testing, permits, training, and O&M costs.
3.1.7.4
Post-Treatment Costs
The post-treatment costs shall include decontamination and decommissioning,
disposal, site restoration, and demobilization.
3.1.8
Regulatory/Institutional Issues
Approvals, licenses and permits required for remediation shall be listed
along with the direct cost and time lines associated with obtaining them.
3.1.9
Observations and Lessons Learned
**************************************************************************
NOTE: Delete any of the following paragraphs when
not applicable.
**************************************************************************
3.1.9.1
Cost Observations and Lessons Learned
Observations or lessons learned concerning cost for each treatment system
shall be summarized. Key factors that affected project costs, and major
items that caused final costs to differ from initial Contractor's bid shall
be considered. Issues that are to be discussed shall include change
orders, reclarifications, liquidated damages, variations in quantities, and
unforeseen conditions. The narrative shall include recommendations for
cost savings in future procurements of each treatment technology.
3.1.9.2
Performance Observations and Lessons Learned
Observations or lessons learned concerning performance of each treatment
system for this contract shall be summarized. Key factors that caused
performance variations from contract requirements/cleanup standards shall
be considered. The narrative shall describe lessons learned from
scaling-up treatability studies to full-scale activities. The description
shall discuss the accuracy of such treatability studies in predicting the
full-scale application cost and performance. Recommendations for improved
performance in future applications, including information from each
treatment vendor shall be discussed.
3.1.9.3
Other Observations and Lessons Learned
Observations or lessons learned from each treatment unit not directly
related to cost or performance shall be summarized.
-- End of Section --
SECTION 01240A
Page 10
Previous Page
